Cite
APA Citation
LeBlanc, H., Pearson, C., Kenkel, J., Blum, L., Ho, P., Luo, A., Laura, R., Zhou, M., Gregorio, J., Luo, A., Ackerman, S., Safina, B., Dornan, D., Alonso, M., & Kowanetz, M. (n.d.). 605 Systemically administered HER2-targeted ISACs provoke a rapid, local response that engages the innate and adaptive arms of the immune system to eradicate tumors in preclinical models. Journal for immunotherapy of cancer, 8, A361–A362. http://access.bl.uk/ark:/81055/vdc_100144721357.0x000006